Hem n Onc 8-5 (3) Flashcards
This patient is presenting with hypertension, a palpable purpuric rash, numbness, tingling, and a history of allergies. A blood test reveals perinuclear antinuclear cytoplasmic antibodies (p-ANCA). All of these clues indicate that this patient has Churg-Strauss syndrome.
Churg-Strauss is a rare granulomatous vasculitis affecting small vessels that is known to be associated with?
eosinophilia and p-ANCA.
c-ANCA (not p-ANCA) is associated with granulomatosis with polyangiitis (previously known as Wegener granulomatosis). Coronary aneurysms are seen in Kawasaki disease, a vasculitis of childhood. Hepatitis B seropositivity is seen in polyarteritis nodosa, and Raynaud phenomenon is associated with?
Buerger disease, a small- and medium-vessel vasculitis.
Suspect Churg-Strauss syndrome in a patient with a history of asthma, eczema, rash, and numbness and tingling in the extremities. It is associated with an?
eosinophilia and positive p-ANCA.
This patient presents with left-sided ataxia and a hemangioblastoma in his right retina. Together, these findings are suggestive of von Hippel-Lindau (VHL) disease.
Patients with von Hippel-Lindau (VHL) disease, which is autosomal dominant, have hemangioblastomas, or cavernous hemangiomas of the retina, cerebellum, and medulla. In addition to a retinal hemangioblastoma, this patient likely has a cerebellar hemangioblastoma, suggested by his ataxia.
Patients with VHL disease are at increased risk of developing?
bilateral renal cell carcinoma ; 10% develop the so-called classic triad of flank pain, palpable flank mass, and hematuria. The deletion of the tumor-suppressing VHL gene on chromosome 3p causes VHL disease.
This gene deletion does not affect the appearance of colon cancer. Colon cancer is more often a sequela of familial adenomatous polyposis (FAP), which is caused by the deletion of the APC gene on chromosome 5.
Astrocytomas are central nervous system tumors that arise in the cranial vault and may be associated with tuberous sclerosis. Tuberous sclerosis is an autosomal dominant genetic disorder caused by a mutation in either the TSC1 or TSC2 gene. The penetrance of tuberous sclerosis is not complete and symptoms can vary. Clinical features of tuberous sclerosis may include ash leaf spots, angiofibromas, and hamartomas (including glioneural hamartomas and subependymal nodules).
Retinal hemangioblastomas, however, are not associated with?
tuberous sclerosis. Although the patient’s fundoscopic image could be interpreted as showing a retinal hamartoma, other symptoms of tuberous sclerosis, such as facial lesions, hypopigmented spots on the skin, and seizures are not present.
Depression is a comorbidity of many diseases, but in a patient with VHL disease there is a higher risk of developing renal cell carcinoma.
This patient presents with a painless neck mass and a trio of constitutional “B” symptoms: fever, night sweats, and weight loss. Although the most common cause of an enlarged cervical node in a young patient is infection, there are a several things that make infection an unlikely diagnosis in this patient:
The patient’s lymph node is painless (lymphadenopathy due to infection is typically tender).
Although the patient has a fever, which is consistent with infection, the patient’s other symptoms (massive weight loss and night sweats) are more consistent with “B” symptoms in?
lymphoma.
The biopsy specimen does not show morphologic evidence of an infectious process (such as follicular hyperplasia or interfollicular expansion).
The patient’s painless lymphadenopathy and “B” symptoms are suggestive of lymphoma. Hodgkin lymphoma has a bimodal distribution, with one peak in young patients and another peak in older patients; overall, the disease is more common in males. The biopsy specimen shown in the stem, which indicates a classic Reed-Sternberg cell amidst a background of lymphocytes, is diagnostic of lymphocyte-rich Hodgkin lymphoma.
In some subtypes of Hodgkin lymphoma, including the lymphocyte depletion, mixed cellularity, and lymphocyte-rich subtypes, the Reed-Sternberg cells are infected with ?
Epstein-Barr virus (EBV). EBV is a herpesvirus; members of this family have a double-stranded, linear DNA genome. The exception is the nodular sclerosing subtype,which is 90% EBV negative.
Viruses with a double-stranded, circular DNA genome include the papillomaviruses and the polyomaviruses. None of these viruses are associated with this patient’s condition.
Viruses with a single-stranded (–), linear RNA genome include the orthomyxoviruses, paramyxoviruses, rhabdoviruses, and filoviruses. None of these viruses are associated with this patient’s condition.
Viruses with a single-stranded (+), linear RNA genome include?
the picornaviruses, caliciviruses, flaviviruses, togaviruses, coronaviruses, and retroviruses. None of these viruses are associated with this patient’s condition.
Viruses with a single-stranded, circular RNA genome include the arenaviruses, bunyaviruses, and delta viruses. None of these viruses are associated with this patient’s condition.
This patient’s tender swollen right calf in the setting of a previous history of calf pain and family history of hypercoagulability is suggestive of a new deep venous thrombosis (DVT). Given that the patient has no history of stasis (recent surgery, long drive or flight) or endothelial damage and considering that his brother had an infarction of the mesenteric vein at a young age, this patient most likely has an inherited thrombophilia. The most common inherited thrombophilia in white individuals is?
factor V Leiden mutation.
Although other hereditary disorders of hypercoaguability, such as protein S deficiency, prothrombin gene mutation, and antiphospholipid antibody syndrome, could explain recurrent thrombotic events, they are not the most prevalent thrombophilias in white individuals and are therefore not the most likely cause of this patient’s thrombosis. Von Willebrand factor deficiency leads to?
Prolonged bleeding and thus does not cause recurrent thrombotic events.
This patient presents with a hard, nontender, movable lump and a history of menopause at age 56. Late menopause (>55 years old) is a known risk factor for breast cancer. Because this patient went through menopause 2 years ago, at age 56, she has had an increased lifetime exposure to estrogen, which increases her risk for breast cancer. Other risk factors include ?
female gender, older age, early menarche (<12 years old), delayed first pregnancy (>30 years old), and family history of a first-degree relative with breast cancer at a young age.
Caffeine intake, history of a nonbloody cyst, St. John’s Wort use, and multiparity do not increase lifetime exposure to estrogen and therefore do not increase?
the risk for breast cancer. A fibroadenoma only slightly increases the risk for breast cancer.
This patient presents with the classic signs and symptoms (night sweats, fever, and weight loss) of Hodgkin lymphoma. The diagnosis is confirmed by the presence of a Reed-Sternberg cell, which are large cells with lobed nuclei that look like owl’s eyes, indicated by the circle in the image.
Vinblastine is part of the ABVD regimen (Adriamycin [doxorubicin], Bleomycin, Vinblastine, and Dacarbazine) used to treat Hodgkin lymphoma. It inhibits microtubular formation of the mitotic spindle, so that affected cells cannot pass through metaphase. Vinblastine is used to treat?
both Hodgkin and non-Hodgkin lymphomas, as well as many solid tumors. Adverse effects include alopecia, constipation, myelosuppression, and, rarely, neurotoxicity.
The other drugs listed do not play a role in treating Hodgkin lymphoma. Cyclosporine is an immunosuppressant used to treat autoimmune disease. Isoniazid is an antibiotic that is part of the multidrug regimen for treating tuberculosis. All-trans retinoic acid is used to treat ?
the APL form of acute myelogenous leukemia. The monoclonal antibody imatinib is used to treat CML.
Firm prostate nodules and unintentional weight loss suggest prostate cancer. The fact that the patient is having back and pelvic pain suggests that his cancer has progressed to metastatic disease. Metastases, from the prostate to the bone, disrupt the normal resorption process of bone formation, leading to a decreased serum calcium level. The prostate-specific antigen (PSA) level is typically elevated in?
prostate cancer. The alkaline phosphatase level should be increased as it is a marker of bone formation.